SATIVEX · ALM-SAT-2011-01
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A postmarketing observational safety registry of patients receiving Sativex (THC:CBD 1:1), included in the product marketing-authorization risk-management plan.
Sponsor: GESTIO ORGANIZACIO COMUNICACIO
Phase: IV
Area: Neuroimmunology